This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Mina Therapeutics Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Pinelopi Andrikakou: Innovator in saRNA Therapeutics
Introduction
Pinelopi Andrikakou is a prominent inventor based in London, GB. She has made significant contributions to the field of molecular biology, particularly in the development of small activating RNAs (saRNAs). Her innovative work focuses on therapeutic applications that can enhance gene expression, specifically targeting the SIRT1 gene.
Latest Patents
Pinelopi holds a patent for "SIRT1-saRNA compositions and methods of use." This invention relates to saRNAs that are useful in upregulating the expression of the SIRT1 gene. The patent also includes therapeutic compositions comprising the saRNA, along with methods for utilizing these compositions effectively.
Career Highlights
Pinelopi is currently associated with Mina Therapeutics Limited, where she continues to advance her research in saRNA technology. Her work is pivotal in exploring new therapeutic avenues for various diseases through gene regulation.
Collaborations
Pinelopi collaborates with notable colleagues, including Siv Anita Hegre and Vikash Reebye, who contribute to her research endeavors and the development of innovative therapeutic solutions.
Conclusion
Pinelopi Andrikakou's contributions to saRNA technology and her patent on SIRT1-saRNA compositions highlight her role as a leading innovator in the field. Her work promises to pave the way for new therapeutic strategies in gene expression regulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile